Detailed Information for S00853

Basic information about inhibitors

IPAD-DB ID S00853
Name Chicago sky blue 6B
Category Synthetic compounds
2D Structure
3D Structure
Molecular Formula C 3 4 H 2 4 N 6 N a 4 O 1 6 S 4
Molecular Weight 992.8 g/mol
IUPAC Name tetrasodium;4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5, 7-disulfonatonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1, 3-disulfonate
InChI InChI=1S/C34H28N6O16S4.4Na/c1-55-23-11-15(3-7-19(23)37-39-21-9-5-17-25(57(43, 44)45)13-27(59(49, 50)51)31(35)29(17)33(21)41)16-4-8-20(24(12-16)56-2)38-40-22-10-6-18-26(58(46, 47)48)14-28(60(52, 53)54)32(36)30(18)34(22)42;;;;/h3-14, 41-42H, 35-36H2, 1-2H3, (H, 43, 44, 45)(H, 46, 47, 48)(H, 49, 50, 51)(H, 52, 53, 54);;;;/q;4*+1/p-4
InChIKey BPHHNXJPFPEJOF-UHFFFAOYSA-J
Canonical SMILES COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)[O-])S(=O)(=O)[O-])O)OC)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+].[Na+]
PubChem CID 17460
DrugBank Accession Number -
CAS Registry Number 2610-05-1

Biological activity data

Ki -
EC50
IC50 2.58 ± 0.57 μM(Aβ42 oligomer)
Inhibition 1.1 ± 0.9%(Aβ42 fibril)
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein Aβ42 oligomers and fibrils
Effects
Research Models In vitro
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 992.8
Hac(Computed by SwissADME) 64
Volume(Computed by ADMETlab 2.0) 773.212
Density(Computed by ADMETlab 2.0) 1.164
nRing(Computed by ADMETlab 2.0) 6
MaxRing(Computed by ADMETlab 2.0) 10
nHet(Computed by ADMETlab 2.0) 26
fChar(Computed by ADMETlab 2.0) -4
nRig(Computed by ADMETlab 2.0) 44
Flexibility(Computed by ADMETlab 2.0) 0.25
Stero Centers(Computed by ADMETlab 2.0) 0
LogS(Computed by ADMETlab 2.0) -5.757
LogD(Computed by ADMETlab 2.0) 0.14

ADMET properties

logP(Computed by ADMETlab 2.0) 2.605
TPSA(Computed by SwissADME) 422.72
Hbond Acceptor(Computed by SwissADME) 20
Hbond Donor(Computed by SwissADME) 4
Rotatable Bonds(Computed by SwissADME) 11

Pharmacokinetics

GI Absorption(Computed by SwissADME) Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -9.83

Druglikeness

Lipinski(Computed by SwissADME) 2
Ghose(Computed by SwissADME) 4
Veber(Computed by SwissADME) 2
Egan(Computed by SwissADME) 2
Muegge(Computed by SwissADME) 3
Bioavailability Score(Computed by SwissADME) 0.17